Health Care

Exelixis tops bottom and topline targets for Q4, stock rises

February 12, 2019

Gilead’s credibility takes a hit on massive NASH-drug failure, rivals jump

February 12, 2019

Q3 Earnings Preview: Canopy Growth likely to continue its recent bullish momentum

February 12, 2019

Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call

February 12, 2019

Earnings preview: Quest Diagnostics’ Q4 results could benefit from M&A activity

February 12, 2019

Aurora Cannabis reports a loss of C$238 million for Q2

February 11, 2019

Four cheap biotech stocks to buy

February 11, 2019

Tilray (TLRY) is reporting Q4 earnings results on March 18. What you need to know

February 11, 2019

Earnings Preview: Positive sentiment around Teva

February 10, 2019

Aurora Cannabis Q2 Earnings: Will the shopping spree continue?

February 8, 2019

IPO update: Two healthcare unicorns went public this week

February 8, 2019

ImmunoGen reports Q4 loss; stock gains as results beat estimates

February 8, 2019

ImmunoGen Q4 Earnings Preview: All eyes on FORWARD trial update

February 7, 2019

Cardinal Health stock surges above 6% on Q2 earnings beat

February 7, 2019

Regeneron Q4 profit soars 371%, beats estimates

February 6, 2019

Boston Scientific Q4 earnings beat on strong sales growth; stock moves up

February 6, 2019

Humana’s stock gains as Q4 results top expectations

February 6, 2019

Eli Lilly Q4 profit misses estimates, cuts 2019 outlook

February 6, 2019

Earnings: Array BioPharma delivers strong Q2 results, investors cheer

February 5, 2019

Gilead Sciences swings to profit in Q4, but misses estimates

February 4, 2019

Earnings preview: Cardiovascular to drive Boston Scientific Q4 results

February 4, 2019